CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome–negative myeloproliferative neoplasms

Discrimination of Philadelphia‐negative myeloproliferative neoplasms (Ph‐MPNs) from reactive hypercytosis and myelofibrosis requires a constellation of testing including driver mutation analysis and bone marrow biopsies. We searched for a biomarker that can more easily distinguish Ph‐MPNs from react...

Descripción completa

Detalles Bibliográficos
Autores principales: Morishita, Soji, Yasuda, Hajime, Yamawaki, Saya, Kawaji, Hideya, Itoh, Masayoshi, Edahiro, Yoko, Imai, Misa, Kogo, Yasushi, Tsuneda, Satoshi, Ohsaka, Akimichi, Hayashizaki, Yoshihide, Ito, Masafumi, Araki, Marito, Komatsu, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893984/
https://www.ncbi.nlm.nih.gov/pubmed/33280191
http://dx.doi.org/10.1111/cas.14763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893984/
https://www.ncbi.nlm.nih.gov/pubmed/33280191
http://dx.doi.org/10.1111/cas.14763

Ejemplares similares